Wearable Injectors Market Size, Trends, Share, Growth & Forecast 2023-2028

IMARC Group, a leading market research company, has recently released a report titled "Wearable Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028". The study provides a detailed analysis of the industry, including the wearable injectors market growth, size, share, trends and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How big is the Wearable Injectors Market?

The global wearable injectors market size reached a value of US$ 6.6 Billion in 2022 and it is expected to reach US$ 15.6 Billion by 2028, exhibiting a CAGR of 14.8% during 2023-2028.

What are Wearable Injectors?

Wearable injectors (WIs) or patch pumps are advanced medical devices used for the convenient and extended delivery of medication. These devices are designed to administer precise doses of medication at optimal intervals and are attached to the skin for subcutaneous delivery of high-viscosity drugs in large volumes. They consist of a drug reservoir, a cannula for administering the medication, and a drive system to ensure accurate dosing. WIs are disposable, user-friendly, and provide minimal discomfort compared to traditional vials and syringes. As a result, they find extensive adoption in hospitals, clinics, and home care settings worldwide.

Request for a sample copy of this report: https://www.imarcgroup.com/wearable-injectors-market/requestsample

What are the growth prospects and trends in the wearable injectors industry?

The wearable injectors market is driven by several factors. Firstly, the increasing prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases, and neurological disorders contributes to market growth. The growing geriatric population, concerns over needle stick injuries, and the demand for continuous monitoring also play a role in driving the market. The COVID-19 pandemic has further boosted the demand for home-based therapies and medical supplies, including wearable injectors. These devices offer benefits such as convenience, comfort, flexible dosing, and reduced hospital visits. Technological advancements like wireless connectivity, Bluetooth integration, digital displays, and smartphone compatibility have accelerated the adoption of wearable injectors. Government initiatives promoting the use of medical tools, along with new product launches, are propelling market growth. North America is one of the largest markets, driven by the high occurrence of chronic diseases, favorable government initiatives, technological advancements, and new product introductions. Competition among key players is expected to increase, with companies implementing competitive strategies to sustain their presence. Examples include the introduction of SmartDose drug delivery platform expansion by West Pharmaceutical Services and the launch of Libertas, a wearable injector by BD. Additionally, rising healthcare expenditure and mergers and acquisitions among leading market players contribute to the positive market outlook.

Browse Full Report with Table of Contents : https://www.imarcgroup.com/wearable-injectors-market

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Type:

On-body
Off-body

Breakup by Technology:

Spring-based
Motor-driven
Rotary Pump
Expanding Battery
Others

Breakup by Application:

Oncology
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Others

Breakup by End Use:

Hospitals and Clinics
Home Care
Others

Market Breakup by Region:

North America (United States, Canada)
Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

Becton Dickinson and Company
CeQur SA
Debiotech SA
Dexcom Inc.
Enable Injections Inc.
Gerresheimer AG
Insulet Corporation
Tandem Diabetes Care Inc.
West Pharmaceutical Services Inc.
Ypsomed AG

Ask an Analyst : https://www.imarcgroup.com/request?type=report&id=3992&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal

About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.